Yasmina Molero

Yasmina Molero

Affiliated to Research
Visiting address: Norra Stationsgatan 69, 11364 Stockholm
Postal address: K8 Klinisk neurovetenskap, K8 CPF Jayaram/Hammarberg, 171 77 Stockholm
Part of:
  • Department of Clinical Neuroscience
  • Centre for Psychiatry Research at CNS
  • Psychological treatment of addiction – Anders Hammarberg and Nitya Jayaram-Lindström's research group

About me

  • I am a researcher at the Department of Clinical Neuroscience (Centre for Psychiatry Research) and affiliated with the Department of Medical Epidemiology & Biostatistics at KI.

    My work focuses on psychiatric epidemiology and pharmacoepidemiology, utilizing data from Swedish national registers, the Swedish Twin Registry, and Swedish cohort studies. My research primarily explores:

    • The relationship between traumatic brain injury and psychiatric and behavioral health, including pharmacological treatment for individuals with  traumatic brain injury.
    • Pharmacological treatment strategies for individuals diagnosed with opioid use disorder.
    • Psychiatric and behavioral risks and benefits of pharmacological treatments, with a focus on suicide, overdoses, accidents, and violence.

    I also contribute to epidemiological studies on psychiatric and behavioral health, including alcohol and drug addiction, gambling disorder, gaming, and risk assessment tools for psychiatry.

    I earned my PhD from the Department of Clinical Neuroscience at KI and completed postdoctoral fellowships at both the Department of Medical Epidemiology & Biostatistics and the Department of Clinical Neuroscience at KI. I also undertook a two-year postdoctoral fellowship at the Department of Psychiatry at the University of Oxford, followed by a two-year role as a visiting researcher at the University of Oxford.

    My research is funded by VR, ALF Medicin, Karolinska Institutet Funds, and Systembolagets Alkoholforskningsråd.

    Current Supervision

    • Anders Nilsson (Postdoc, Department of Clinical Neuroscience, Centre for Psychiatry Research, KI): Research on gaming and mental health.
    • Andrea Klang (PhD Student, Department of Medical Sciences, Uppsala University): Co-supervisor for PhD project on long-term outcomes and rehabilitation after traumatic brain injury.
    • Charlotte Wesslén (PhD Student, Department of Medical Sciences, Uppsala University): Co-supervisor for PhD project on the role of genetic variation in traumatic brain injury outcomes.
    • Andreas Hurme-Lundin (PhD Student, Department of Neuroscience, KI): Co-supervisor for PhD project for traumatic brain injury susceptibility and long-term outcomes.

    Previous Supervision

    • Eva Norén Selinus (Department of Clinical Neuroscience, KI): Co-supervisor for PhD project on ADHD and psychosocial outcomes.
    • Remus-Giulio Anghel (Oxford Brookes University, UK): Supervisor for BSc (Hons) Biomedical Science degree project on pharmacoepidemiology.
    • Sandra Tegvik (Medicine Programme, KI): Supervisor for medical degree project on pharmacoepidemiology in pediatric traumatic brain injury.

Articles

All other publications

Grants

  • Swedish Research Council
    1 January 2025 - 31 December 2028
    Traumatic Brain Injury (TBI) affects over 60 million people annually worldwide, leading to significant disabilities and increasing the risk of dementia. Despite TBI´s heterogeneity and varying outcomes among similarly injured patients, current treatment relies on a uniform, one-size-fits-all approach, often resulting in suboptimal care. This one-size-fits-all approach fails to accommodate the individual variations and complexities inherent in each case of TBI, leading to suboptimal outcomes. Recognizing the need for personalized treatment strategies, this project proposes the integration of clinical variables, head CT-scans, biological, high-resolution physiological data, and genetic variations, cognitive reserve, harnessing comprehensive Swedish and international TBI datasets, bolstered by extensive Swedish linkage registers. Employing machine learning algorithms, this approach strives for customized interventions and accurate prognosis tools, transforming care in neurointensive clinics. Additionally, addressing the gap between animal studies and human trials, we introduce a humanized in vivo model for TBI research, essential for testing neuroprotective drugs and understanding human cell responses. Combining clinical and experimental efforts with advanced data-driven techniques, our project targets the discovery of effective drug targets to improve TBI recovery, underscored by a humanized model for direct relevance to patient care.

Employments

  • Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2024-2027

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2011

News from KI

Events from KI